This link in the pharma supply chain is undergoing a major transformation propelled by technological advancements, regulatory ...

Overall, Statista predicted the worldwide pharma industry market revenue will increase 4.5% between 2024 and 2025. Oncology medication revenue is projected to grow 7.6%, reaching $208.86 billion ...

Learn more about whether Kymera Therapeutics, Inc. or Ultragenyx Pharmaceutical Inc. is a better investment based on AAII's ...

Eli Lilly wants the most optimal locations to host its new manufacturing facilities in the U.S.—and it’s open to pitche | Eli ...

Staff and funding cuts to the NIH, FDA and USAID could have downstream implications for R&D in the pharma industry, experts ...

With proper data governance, the pharma industry can improve patient-centricity in trials and bring lifesaving therapies to ...

New Jersey's powerful pharmaceutical industry, already under pressure to rein in prices, is facing new headwinds from a Trump ...

Large mergers and acquisitions in the Indian pharmaceutical market are unlikely soon due to various uncertainties, says GV ...

Lisa Jarvis is a Bloomberg Opinion columnist covering biotech, health care and the pharmaceutical industry. Previously, she ...

The time to invest in NCDs through primary health care is now.” IFPMA represents the innovative pharmaceutical industry at the international level, engaging in official relations with the United ...

The Special Investment Facilitation Council (SIFC) endorsed the government’s deregulation policy for pharmaceutical sector ...